Business Description
Genoway SA
ISIN : FR0004053510
Description
Financial Strength
7/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.59 | |||||
Equity-to-Asset | 0.55 | |||||
Debt-to-Equity | 0.42 | |||||
Debt-to-EBITDA | 1.13 | |||||
Interest Coverage | 1.43 | |||||
Piotroski F-Score | 8/9 | |||||
Altman Z-Score | 2.57 | |||||
Beneish M-Score | -2.93 | |||||
WACC vs ROIC |
Growth Rank
9/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 9.2 | |||||
3-Year EBITDA Growth Rate | 62.8 | |||||
3-Year Book Growth Rate | 17.1 |
Momentum Rank
7/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 62.79 | |||||
9-Day RSI | 54.27 | |||||
14-Day RSI | 51.42 | |||||
6-1 Month Momentum % | -5.59 | |||||
12-1 Month Momentum % | 6.84 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 2.11 | |||||
Quick Ratio | 2 | |||||
Cash Ratio | 0.51 | |||||
Days Inventory | 342.8 | |||||
Days Sales Outstanding | 128.68 | |||||
Days Payable | 761.1 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -6.4 | |||||
Shareholder Yield % | 5.25 |
Profitability Rank
5/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 93.8 | |||||
Operating Margin % | 0.78 | |||||
Net Margin % | 7.82 | |||||
FCF Margin % | 6.39 | |||||
ROE % | 9.28 | |||||
ROA % | 4.83 | |||||
ROIC % | 0.61 | |||||
ROC (Joel Greenblatt) % | 16.22 | |||||
ROCE % | 8.45 | |||||
Years of Profitability over Past 10-Year | 7 |
GF Value Rank
7/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PE Ratio | 20.63 | |||||
PE Ratio without NRI | 16.28 | |||||
Shiller PE Ratio | 71.64 | |||||
Price-to-Owner-Earnings | 7.5 | |||||
PEG Ratio | 0.55 | |||||
PS Ratio | 1.61 | |||||
PB Ratio | 1.85 | |||||
Price-to-Tangible-Book | 2.92 | |||||
Price-to-Free-Cash-Flow | 25.26 | |||||
Price-to-Operating-Cash-Flow | 10.53 | |||||
EV-to-EBIT | 17.05 | |||||
EV-to-EBITDA | 5.52 | |||||
EV-to-Revenue | 1.76 | |||||
EV-to-FCF | 27.48 | |||||
Price-to-Projected-FCF | 1.99 | |||||
Price-to-DCF (Earnings Based) | 1.38 | |||||
Price-to-DCF (FCF Based) | 2.14 | |||||
Price-to-Median-PS-Value | 1.13 | |||||
Price-to-Peter-Lynch-Fair-Value | 0.69 | |||||
Price-to-Graham-Number | 1.5 | |||||
Price-to-Net-Current-Asset-Value | 10.45 | |||||
Earnings Yield (Greenblatt) % | 5.87 | |||||
FCF Yield % | 3.98 | |||||
Forward Rate of Return (Yacktman) % | 20.89 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Genoway SA Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil €) | 20.047 | ||
EPS (TTM) (€) | 0.191 | ||
Beta | 0.7 | ||
Volatility % | 23.57 | ||
14-Day RSI | 51.42 | ||
14-Day ATR (€) | 0.165433 | ||
20-Day SMA (€) | 4.1765 | ||
12-1 Month Momentum % | 6.84 | ||
52-Week Range (€) | 3.5 - 4.91 | ||
Shares Outstanding (Mil) | 8.18 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 8 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Genoway SA Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Genoway SA Stock Events
Event | Date | Price(€) | ||
---|---|---|---|---|
No Event Data |
Genoway SA Frequently Asked Questions
What is Genoway SA(XPAR:ALGEN)'s stock price today?
When is next earnings date of Genoway SA(XPAR:ALGEN)?
Does Genoway SA(XPAR:ALGEN) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |